Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huamoyan Keli with or without diacerein for knee osteoarthritis
ChiCTR1800018531Phase 3Not yet recruiting
- Sponsor
- Second Hospital of Hebei Medical University, Department of Orthopaedics
- Start
- Oct 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Huamoyan Keli and diacerein in knee osteoarthritis (OA) (3 arms), sponsored by Second Hospital of Hebei Medical University, Department of Orthopaedics. Primary endpoint: WOMAC scale. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
Huamoyan Kelidiacerein
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR1800018531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018531.